ALFA Finder| Revenue growth | 71% YoY growth for FY26 to INR 801cr. |
|---|---|
| Margins | EBITDA margin improved from 30% to 44% in one year. |
| Demand visibility | Strong; 26% of sales now from health insurance; UPSS scheme tailwinds. |
| Management confidence | High; targets 4-5x PAT growth over next 3-5 years. |
Growth
FY26 Revenue INR 801cr (+71% YoY); EBITDA INR 349cr (+149%); PAT INR 222cr (+177%); EBITDA margin 44%.
Outlook
Targeting 7,000-10,000 beds in 3-5 years; minimum INR 300cr PAT guidance for FY27; expansion into luxury wellness.
Risks
One-time provisions in Q4 impact short-term optics; geopolitical panics (e.g., Iran-USA) causing deferred elective admissions.
Last quarter's promises, checked
Delivered
- Guided INR 750cr FY26 revenue → delivered INR 801cr (= BEAT)
- Targeted 2,850 beds for FY26 → delivered 2,850 beds (= BEAT)
- Guided 20-25% EBITDA margin → delivered 44% (= BEAT)
Partly delivered
- Targeted 70-80% occupancy → delivered 58% (= PARTIAL)
Earnings Call filed with NSE, NSE: JSLL. Summary written with AI assistance from the document.
Jeena Sikho Lifecare Ltd: key numbers
- Share price
- ₹367.95
- Market cap
- ₹4,575 Cr
- Revenue (annual)
- ₹801.4 Cr
- Net profit (annual)
- ₹221.8 Cr
- P/E (TTM)
- 19.3×Sector 43.8×
- Promoter holding
- 63.67%+0.05% QoQ
- FII holding
- 4.49%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jeena Sikho Lifecare Ltd
All →Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
Jeena Sikho Lifecare Merger & Restructuring Worth ₹0.03 Cr
Jeena Sikho Lifecare's board approved incorporating Ayugenomics Private Limited as a subsidiary, holding 60%. The company will invest Rs 3 lakh, subject to statutory approvals.
- Value
- ₹0.03 Cr
Jeena Sikho Lifecare Board Meeting Date
Jeena Sikho Lifecare has scheduled a board meeting for 14 Nov 2026 to consider unaudited Q1 FY27 financial results. The trading window is closed from 1 Oct to 16 Nov 2026.
Jeena Sikho Lifecare Other Announcement
Jeena Sikho Lifecare Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Jeena Sikho Lifecare Employee Stock Options
Jeena Sikho Lifecare allotted 23,374 equity shares under its ESOS 2024 scheme. This allotment increases the company's total paid-up equity share capital.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare Limited has launched eight new Ayurvedic healthcare, wellness, and nutraceutical products. These new offerings are now available in the domestic market.